Scrub Typhus with Sepsis and Acute Respiratory Distress Syndrome
Scrub typhus is a major infectious threat in the Asia-Pacific region. We report an unusual case of scrub typhus in a patient in Singapore who presented with sepsis and acute respiratory distress syndrome but lacked the pathognomonic eschar. The patient recovered after appropriate diagnosis and doxycycline treatment. Rickettsial diseases should be included in the differential diagnosis of febrile illnesses in regions where the diseases are endemic, and absence of eschar should not be the criterion used to rule out scrub typhus. O n 3 October 2011, a 35-year-old male became acutely ill and was admitted to a hospital in a neighboring country following 4 days of an undifferentiated febrile illness. On admission, the patient had fever, chills, giddiness, nonspecific abdominal pain, cough with nonpurulent sputum, and lethargy. His condition rapidly deteriorated, requiring mechanical ventilation for respiratory distress, followed by septic shock on the third day of hospitalization. He received empirical intravenous moxifloxacin and meropenem, oral clarithromycin, and vasopressor support. As his condition did not improve, he was transferred to Singapore on day 4 of hospitalization.
On admission in Singapore on 6 October 2011, the patient was febrile (38.0°C) with a blood pressure of 120/63 mmHg supported by 2 g/kg/min of dopamine. His oxygen saturation was 97% with a fraction of inspired O 2 of 60%. Physical examination disclosed no significant rash. His abdomen was flushed, soft, and nontender. Chest auscultation revealed bilateral crepitations.
A chest radiograph showed bilateral alveolar shadows consistent with acute respiratory distress syndrome (ARDS). Abdominal sonography and echocardiography findings were normal. Laboratory data (Table 1) revealed leukocytosis, thrombocytopenia, elevated aspartate aminotransferase and alanine aminotransferase levels, and mild renal impairment. He was diagnosed with sepsis syndrome complicated by ARDS. The differential diagnosis included melioidosis, leptospirosis, rickettsiosis, and viral infections, including influenza virus. Serologic tests for hantavirus, melioidosis, dengue virus, Leptospira, chikungunya virus, Nipah virus, and Mycoplasma were negative. Urine, blood, and sputum cultures also were negative for Legionella and pneumococcal antigens. A Widal, Weil-Felix test (agglutination test for the diagnosis of rickettsial infections) was also performed with a serum sample (taken on 6 October 2011) but was negative (all titers were less than 1:40). He was empirically treated with oral oseltamivir, doxycycline, intravenous amoxicillin-clavulanate, and ceftazidime. He became afebrile 48 h after admission in Singapore. Bronchoalveolar lavage was performed on day 2 after admission, and cultures were sterile. In view of his severe ARDS, intravenous hydrocortisone, beginning with an initial dose of 100 mg every 8 h, was initiated on day 3 after admission and subsequently tapered off. Chest radiography and laboratory marker (C-reactive protein, procalcitonin) level tests on day 6 after admission showed much improvement. He was successfully weaned from mechanical ventilatory support on day 7.
Serum samples taken on day 9 of illness were tested with a recently developed Western blot assay (developed at the U.S. Naval Medical Research Center [NMRC] ) that can recognize and differentiate various febrile illnesses of bacterial origin (our un- published data). The serum testing was performed at the Emerging Infectious Diseases Division, Duke-NUS Graduate Medical School, Singapore, for murine typhus, spotted fever, scrub typhus, Q fever, and leptospirosis. The assay uses recombinant antigens/ whole-cell antigens from various pathogens (Rickettsia typhi, R. conorii, Orientia tsutsugamushi, Coxiella burnetii, and Leptospira interrogans). The serum was negative for all of the pathogens tested for, except O. tsutsugamushi ( Fig. 1A and B) , and a mixture of recombinant 56-kDa antigens (1) derived from the most prevalent serotypes of O. tsutsugamushi (Karp, Kato, Gilliam, and TA763) was detected. Figure 1C represents the protein gel showing the presence of various recombinant/whole-cell antigens used in the Western blot assay. Figure 1D and E show the positivecontrol Western blot assays detecting these antigens in the serum of a confirmed scrub typhus patient. The results were also confirmed by using a prototype rapid chromatographic immunoassay kit developed by InBios in collaboration with NMRC for scrub typhus detection. O. tsutsugamushi infection was further verified by an in-housedeveloped real-time PCR assay that detects the 56-kDa proteinencoding gene. This real-time PCR assay was sensitive enough to detect as few as 10 genomic equivalents of O. tsutsugamushi and had been tested for specificity against 15 different bacterial species with no cross-reactivity, demonstrating 100% specificity for O. tsutsugamushi (our unpublished data). PCR is considered a very sensitive and specific method for the detection of O. tsutsugamushi rickettsial DNA (2, 3). The PCR was performed with whole blood taken from the patient on day 9 of illness (at DSO National Laboratories, Singapore). The primers and probe used were forward primer 5=-GTTGTCGTTGCCGTTTTCA-3=, reverse primer 5=-TGGATCCAAGCGAGCAGA-3=, and TaqMan probe 5=-(6-carboxyfluorescein)-TAGTGCGATAGAATTGGATGAT GAAGGA-(Black Hole Quencher 1)-3=. The real-time PCR conditions used were 95°C for 2 min and 50 cycles of 95°C for 0 s, 60°C for 6 s, and 72°C for 12 s. Figure 2 shows the fluorescence profile (relative fluorescence units) representing positive detection of the O. tsutsugamushi 56-kDa rickettsial antigen gene in a whole-blood sample (sample 2); a serum sample (sample 1) was negative. We also confirmed the sequence of the PCR product obtained in this study as that of the 56-kDa rickettsial antigen gene.
In view of the confirmed scrub typhus diagnosis, oseltamivir, intravenous amoxicillin-clavulanate, and ceftazidime were stopped and the patient received 2 weeks of oral doxycycline (100 mg twice daily) and recovered completely. He was discharged from the hospital on day 11 following admission.
In this report, we present the case of a patient with clinically severe scrub typhus who was hospitalized in Singapore with the complication of sepsis syndrome with ARDS. However, no characteristic eschar was present and the patient recovered completely with timely diagnosis and treatment. Improvement in the health of the patient was observed from admission, as doxycycline ther- apy was initiated on day 1 after his transfer to Singapore. While most patients with scrub typhus present with a relatively mild illness, this case illustrates its potential to cause severe clinical manifestations.
Scrub typhus is an acute febrile illness caused by the obligate mite-borne Gram-negative bacterium O. tsutsugamushi (family Rickettsiaceae). It is endemic to the Tsutsugamushi Triangle of the Asia-Pacific region (4), accounts for 23% of all febrile illness in that region, and can have a mortality rate of up to 35% if left untreated (1). The disease is an important public health problem (5) (6) (7) (8) (9) , and an estimated one billion people live in areas at risk for scrub typhus with an estimated one million annual cases (10) . Scrub typhus was the most notable rickettsiosis affecting U.S. troops in WWII in the China-Burma-India theater of operations and had a higher mortality rate than any other infectious disease there (8) . Many new or imported cases of scrub typhus have also been reported from regions outside the traditional Asia-Pacific region (11) (12) (13) .
Scrub typhus, like most rickettsial diseases, is generally difficult to diagnose because it produces clinical characteristics similar to those of many other tropical febrile illnesses. The clinical severity of scrub typhus ranges from mild febrile illness to a fatal outcome. Complications may include encephalitis, interstitial pneumonia, hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency, ARDS, acute renal failure, myocarditis, septic shock, and death (14, 15) . Pulmonary involvement frequently occurs in mild cases and is the principal cause of death in severe disease (6, 7) . Severe complications such as sepsis and ARDS are typically the results of delayed diagnosis and treatment. When treated with an appropriate antibiotic (doxycycline, tetracycline, or chloramphenicol), patients typically become afebrile within 48 h.
This patient was a vegetable farm supervisor with no significant medical or travel history. An increase in rat infestation was noted at the farm where he worked in the weeks leading to his illness. He subsequently reported having noticed a dead rat in his car, which he removed with his bare hands about a week prior to falling ill. While the patient's history and clinical presentation were suggestive of a scrub typhus diagnosis, he did not have the pathognomonic eschar. The patient did not respond to quinolone and macrolide therapy. Scrub typhus is well known to be unresponsive or show only a suboptimal response to quinolones, beta-lactams, penicillins, clarithromycin, and cephalosporins (8, 16, 17) , and in northern Thailand, there has been a reported case of resistance to chloramphenicol and doxycycline (18) . It is also notable that the Widal, Weil-Felix test, a generally used diagnostic test for rickettsial diseases, showed a negative result with the patient sample. This result is not surprising, as it is well known that the Widal, Weil-Felix test is not very sensitive for the diagnosis of scrub typhus (19) .
Although Singapore is a major economic hub attracting a large number of travelers, there are only scant published reports of the prevalence of rickettsial disease in Singapore (13, (20) (21) (22) (23) . Because scrub typhus is endemic in countries neighboring Singapore, health care providers must be aware of a patient's travel history. While clinical signs such as lymphadenopathy, splenomegaly, rash, and fever are nonspecific, an eschar, if present, is pathognomonic in the diagnosis of scrub typhus. However, eschars are rare among Southeast Asian patients (24) . The nonspecific presentation of patients and the absence of a characteristic eschar make misdiagnosis and underreporting of scrub typhus common.
This study underscores the importance of including scrub typhus and other rickettsial diseases in the differential diagnosis of patients with acute febrile illnesses of unknown origin in this region. Although eschar is a pathognomonic feature of scrub ty- A serum sample (sample 1) was negative. Negative 1 is the negative control for the serum sample (sample 1), and negative 2 is the negative control for the blood sample (sample 2). The threshold line is shown in red, and the amplification threshold value of 0.257 is indicated.
phus, its absence does not rule out scrub typhus. Awareness of unusual manifestations of scrub typhus such as sepsis syndrome and ARDS and the timely administration of empirical treatment with doxycycline in suspicious cases can greatly help to decrease the morbidity and mortality associated with rickettsial diseases.
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